FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Syndicate content

pandemic news from FierceBiotech

News

GSK bird flu vaccine wins race for European OK

After investing about $2 billion in development efforts, GlaxoSmithKline has won European approval for the first bird flu vaccine that can be used either in advance of or in the early days of a human Read more...

ALSO NOTED: Sirtris, NCI collaborate on cancer models; Kylin expands in Indiana; and much more...

> Sirtris announced a collaboration with the National Cancer Institute to its enzyme activators in cancer models. Read more...

SPOTLIGHT: GAO questions antidotes for pandemic

The GAO says that a pandemic vaccine can offer little help during the crucial initial stages of an outbreak. The Department of Health and Human Services has estimated that it would take 20 to 23 Read more...

SPOTLIGHT: Flu pandemic "inevitable"

Australia's health minister says that it's only a matter of time before a flu pandemic hits the country. But he's not releasing the country's antiviral stockpile in the face of a deadly outbreak of Read more...
Tags: pandemic   Australia  

Press Release: Novavax Licenses Wyeth's Virus-Like Particle Technology

Press Release: Novavax Licenses Wyeth's Virus-Like Particle Technology

Read more...

CDC offers advice in combating a pandemic

With experimental vaccines in short supply, the CDC has outlined a series of public responses to a flu pandemic. Saying the U.S. needs to prepare for a "Category 5" pandemic, the agency suggests that schools should be closed and public events should be canceled to help slow the spread of a dangerous outbreak. In addition, the CDC is suggesting that business shifts should be staggered and entire families should stay home if one of them is sick. But the CDC is warning against closing state …

Read more...
Tags: Tamiflu   Avian Flu   pandemic  

Press Release: GSK Awarded $63 Million HHS Contract for Pandemic Vaccine Research and Development

Press Release: GSK Awarded $63 Million HHS Contract for Pandemic Vaccine Research and Development

Read more...

HHS issues contracts for pandemic vaccine research

GlaxoSmithKline has won a $63.3 million contract from Health and Human Services to develop pre-pandemic and pandemic vaccines, supporting its research into adjuvants that boost the effectiveness of vaccines. The 5-year contract also gives the U.S. Government the option to fund an additional $44 million of future clinical development programs related to antigen-sparing pandemic vaccines. Iomai, meanwhile, announced it will receive a contract from HHS to fund the development of a …

Read more...

Bird flu outbreaks spread across Asia

Indonesia is preparing more hospitals to take victims of a new bird flu outbreak, as one facility reports that its small isolation ward has been filled. At least one family cluster has been affected as officials report the deaths of at least four people in that country in just the past week. Japan, meanwhile, is reporting that it has confirmed the presence of the lethal H5N1 version of bird flu in poultry, its first …

Read more...

Press Release: Juvaris BioTherapeutics Announces First Round Closing Of Series A Financing

Press Release: Juvaris BioTherapeutics Announces First Round Closing Of Series A Financing

Read more...

Get more pandemic coverage at: